ID MANBA_HUMAN Reviewed; 879 AA. AC O00462; Q96BC3; Q9NYX9; DT 15-JUL-1998, integrated into UniProtKB/Swiss-Prot. DT 16-AUG-2004, sequence version 3. DT 03-NOV-2009, entry version 86. DE RecName: Full=Beta-mannosidase; DE EC=3.2.1.25; DE AltName: Full=Lysosomal beta A mannosidase; DE AltName: Full=Mannanase; DE Short=Mannase; DE Flags: Precursor; GN Name=MANBA; Synonyms=MANB1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], INVOLVEMENT IN LYSOSOMAL RP BETA-MANNOSIDASIS, AND VARIANT ILE-253. RX MEDLINE=98046009; PubMed=9384606; DOI=10.1093/hmg/7.1.75; RA Alkhayat A.H., Kraemer S.A., Leipprandt J.R., Macek M., Kleijer W.J., RA Friderici K.H.; RT "Human beta-mannosidase cDNA characterization and first identification RT of a mutation associated with human beta-mannosidosis."; RL Hum. Mol. Genet. 7:75-83(1998). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RA Chang H.-M., Tsai S.-F.; RT "Genome sequencing of the chromosome 4q region implicated in human RT hepatocellular carcinoma pathogenesis."; RL Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT MET-701. RC TISSUE=Muscle; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). CC -!- FUNCTION: Exoglycosidase that cleaves the single beta-linked CC mannose residue from the non-reducing end of all N-linked CC glycoprotein oligosaccharides. CC -!- CATALYTIC ACTIVITY: Hydrolysis of terminal, non-reducing beta-D- CC mannose residues in beta-D-mannosides. CC -!- PATHWAY: Glycan metabolism; N-glycan degradation. CC -!- SUBCELLULAR LOCATION: Lysosome. CC -!- DISEASE: Defects in MANBA are the cause of a mild disorder that CC affects peripheral and central nervous system myelin. CC -!- DISEASE: Defects in MANBA are the cause of lysosomal beta- CC mannosidosis [MIM:248510]. Beta-mannosidosis is an autosomal CC recessive lysosomal storage disease of glycoprotein catabolism. CC Clinical features are heterogeneous with a wide range of symptoms CC and age of onset. The disease is associated with a range of CC neurological involvement, including various degrees of mental CC retardation in most of the cases, hearing loss and speech CC impairment, hypotonia, epilepsy and peripheral neuropathy. CC Affected individuals have a profound reduction in beta-mannosidase CC activity in plasma, fibroblasts and leukocytes. CC -!- SIMILARITY: Belongs to the glycosyl hydrolase 2 family. CC -!- WEB RESOURCE: Name=GeneReviews; CC URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/MANBA"; CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; U60337; AAC39573.1; -; mRNA. DR EMBL; AF213884; AAF35233.1; -; Genomic_DNA. DR EMBL; BC015743; AAH15743.1; -; mRNA. DR IPI; IPI00298793; -. DR RefSeq; NP_005899.3; -. DR UniGene; Hs.480415; -. DR STRING; O00462; -. DR CAZy; GH2; Glycoside Hydrolase Family 2. DR PhosphoSite; O00462; -. DR PeptideAtlas; O00462; -. DR PRIDE; O00462; -. DR Ensembl; ENST00000226578; ENSP00000226578; ENSG00000109323; Homo sapiens. DR GeneID; 4126; -. DR KEGG; hsa:4126; -. DR NMPDR; fig|9606.3.peg.24477; -. DR UCSC; uc003hwg.1; human. DR CTD; 4126; -. DR GeneCards; GC04M103771; -. DR H-InvDB; HIX0022086; -. DR HGNC; HGNC:6831; MANBA. DR MIM; 248510; phenotype. DR MIM; 609489; gene. DR Orphanet; 118; Beta-mannosidosis. DR PharmGKB; PA30577; -. DR HOGENOM; O00462; -. DR HOVERGEN; O00462; -. DR OMA; FVRKEQC; -. DR BRENDA; 3.2.1.25; 247. DR NextBio; 16200; -. DR ArrayExpress; O00462; -. DR Bgee; O00462; -. DR CleanEx; HS_MANBA; -. DR Genevestigator; O00462; -. DR GermOnline; ENSG00000109323; Homo sapiens. DR GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell. DR GO; GO:0004567; F:beta-mannosidase activity; TAS:ProtInc. DR GO; GO:0043169; F:cation binding; IEA:InterPro. DR GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro. DR GO; GO:0006464; P:protein modification process; NAS:UniProtKB. DR InterPro; IPR006103; Glyco_hydro_2_TIM. DR InterPro; IPR013781; Glyco_hydro_sg_catalytic. DR Gene3D; G3DSA:3.20.20.80; Glyco_hydro_cat; 1. DR Pfam; PF02836; Glyco_hydro_2_C; 1. PE 1: Evidence at protein level; KW Complete proteome; Glycoprotein; Glycosidase; Hydrolase; Lysosome; KW Polymorphism; Signal. FT SIGNAL 1 17 Potential. FT CHAIN 18 879 Beta-mannosidase. FT /FTId=PRO_0000012166. FT ACT_SITE 457 457 Proton donor (By similarity). FT CARBOHYD 28 28 N-linked (GlcNAc...) (Potential). FT CARBOHYD 35 35 N-linked (GlcNAc...) (Potential). FT CARBOHYD 77 77 N-linked (GlcNAc...) (Potential). FT CARBOHYD 280 280 N-linked (GlcNAc...) (Potential). FT CARBOHYD 284 284 N-linked (GlcNAc...) (Potential). FT CARBOHYD 297 297 N-linked (GlcNAc...) (Potential). FT CARBOHYD 302 302 N-linked (GlcNAc...) (Potential). FT CARBOHYD 763 763 N-linked (GlcNAc...) (Potential). FT VARIANT 253 253 V -> I (in dbSNP:rs227368). FT /FTId=VAR_026232. FT VARIANT 253 253 V -> L (in dbSNP:rs227368). FT /FTId=VAR_059311. FT VARIANT 701 701 T -> M (in dbSNP:rs2866413). FT /FTId=VAR_026233. FT CONFLICT 70 70 Y -> H (in Ref. 1; AAC39573). SQ SEQUENCE 879 AA; 100895 MW; FE8173A4276B722E CRC64; MRLHLLLLLA LCGAGTTAAE LSYSLRGNWS ICNGNGSLEL PGAVPGCVHS ALFQQGLIQD SYYRFNDLNY RWVSLDNWTY SKEFKIPFEI SKWQKVNLIL EGVDTVSKIL FNEVTIGETD NMFNRYSFDI TNVVRDVNSI ELRFQSAVLY AAQQSKAHTR YQVPPDCPPL VQKGECHVNF VRKEQCSFSW DWGPSFPTQG IWKDVRIEAY NICHLNYFTF SPIYDKSAQE WNLEIESTFD VVSSKPVGGQ VIVAIPKLQT QQTYSIELQP GKRIVELFVN ISKNITVETW WPHGHGNQTG YNMTVLFELD GGLNIEKSAK VYFRTVELIE EPIKGSPGLS FYFKINGFPI FLKGSNWIPA DSFQDRVTSE LLRLLLQSVV DANMNTLRVW GGGIYEQDEF YELCDELGIM VWQDFMFACA LYPTDQGFLD SVTAEVAYQI KRLKSHPSII IWSGNNENEE ALMMNWYHIS FTDRPIYIKD YVTLYVKNIR ELVLAGDKSR PFITSSPTNG AETVAEAWVS QNPNSNYFGD VHFYDYISDC WNWKVFPKAR FASEYGYQSW PSFSTLEKVS STEDWSFNSK FSLHRQHHEG GNKQMLYQAG LHFKLPQSTD PLRTFKDTIY LTQVMQAQCV KTETEFYRRS RSEIVDQQGH TMGALYWQLN DIWQAPSWAS LEYGGKWKML HYFAQNFFAP LLPVGFENEN TFYIYGVSDL HSDYSMTLSV RVHTWSSLEP VCSRVTERFV MKGGEAVCLY EEPVSELLRR CGNCTRESCV VSFYLSADHE LLSPTNYHFL SSPKEAVGLC KAQITAIISQ QGDIFVFDLE TSAVAPFVWL DVGSIPGRFS DNGFLMTEKT RTILFYPWEP TSKNELEQSF HVTSLTDIY //